Protheragen Announces Enhanced Pharmacodynamic Study Platform for Anti-Obesity Drug Development
United States, August 12, 2026 — More than one billion people worldwide suffer from obesity. As this global health crisis deepens, the demand for effective anti-obesity drugs is growing exponentially. However, the path to regulatory… Read More »Protheragen Announces Enhanced Pharmacodynamic Study Platform for Anti-Obesity Drug Development





